Breast cancer is the second highest diagnosed cancer in women in the US and, as of 2020, the most commonly diagnosed cancer in women worldwide. 1 In 15–20 percent of these cases, the growth factor ...
The phase I study by Storniolo et al in this issue of Journal of Clinical Oncology, 1 which evaluates the combination of lapatinib (a selective small-molecule ErbB1 and ErbB2 tyrosine kinase inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results